BORELLA, NICOLÒ DIEGO
 Distribuzione geografica
Continente #
AS - Asia 98
NA - Nord America 61
EU - Europa 54
SA - Sud America 14
AF - Africa 3
Totale 230
Nazione #
US - Stati Uniti d'America 60
SG - Singapore 53
HK - Hong Kong 16
FR - Francia 12
IT - Italia 12
BR - Brasile 10
DE - Germania 7
CN - Cina 6
FI - Finlandia 5
GB - Regno Unito 5
KR - Corea 5
PK - Pakistan 4
AT - Austria 3
ID - Indonesia 3
RU - Federazione Russa 3
UZ - Uzbekistan 3
VN - Vietnam 3
IN - India 2
NL - Olanda 2
TG - Togo 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IQ - Iraq 1
JO - Giordania 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 230
Città #
Dallas 35
Singapore 28
Hong Kong 15
Munich 5
El Paso 4
Ascot 3
Ashburn 3
Helsinki 3
Jakarta 3
Nantes 3
Seongdong-gu 3
Villafranca di Verona 3
Amsterdam 2
Baranzate 2
Bussolengo 2
Islamabad 2
Lomé 2
Mardan 2
Santa Clara 2
Shanghai 2
Tashkent 2
Turku 2
Amman 1
Asunción 1
Aurora 1
Azusa 1
Baghdad 1
Bexley 1
Brooklyn 1
Burgas 1
Caapiranga 1
Cabo Frio 1
Canela 1
Coro 1
Crete 1
Dublin 1
Falkenstein 1
Fremont 1
Itaquaquecetuba 1
Ituiutaba 1
Kolkata 1
Lagos 1
Lauterbourg 1
Lima 1
London 1
Louisville 1
Manaus 1
Mexico City 1
Miami 1
Nuremberg 1
Olomouc 1
Quận Hai 1
Quận Một 1
Quận Tân Phú 1
Rennes 1
Rio de Janeiro 1
Samarkand 1
San Francisco 1
Secaucus 1
São José do Rio Preto 1
Taubaté 1
Tianjin 1
Turmero 1
Verona 1
Vienna 1
Totale 171
Nome #
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 77
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 43
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 35
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis 34
Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study 24
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study 23
Totale 236
Categoria #
all - tutte 966
article - articoli 853
book - libri 0
conference - conferenze 113
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/202597 2 3 2 8 0 3 12 3 7 10 14 33
2025/2026134 53 77 4 0 0 0 0 0 0 0 0 0
Totale 236